Prithviraj Bose, MD, of the University of Texas MD Anderson Cancer Center, discusses his 2023 American Society of Clinical Oncology Annual Meeting abstract titled “Consistency of pacritinib for spleen and symptom reduction in patients with myelofibrosis regardless of cytopenias.”